Quadrature Capital Ltd Has $2.29 Million Holdings in Utah Medical Products, Inc. (NASDAQ:UTMD)

Quadrature Capital Ltd boosted its holdings in shares of Utah Medical Products, Inc. (NASDAQ:UTMD) by 177.6% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 32,310 shares of the medical instruments supplier’s stock after buying an additional 20,671 shares during the quarter. Quadrature Capital Ltd owned approximately 0.90% of Utah Medical Products worth $2,294,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of the business. Northwest Financial Advisors acquired a new position in shares of Utah Medical Products in the fourth quarter valued at approximately $25,000. EntryPoint Capital LLC grew its position in shares of Utah Medical Products by 124.1% in the first quarter. EntryPoint Capital LLC now owns 3,240 shares of the medical instruments supplier’s stock valued at $230,000 after purchasing an additional 1,794 shares during the last quarter. BNP Paribas Financial Markets grew its position in shares of Utah Medical Products by 101.7% in the fourth quarter. BNP Paribas Financial Markets now owns 3,766 shares of the medical instruments supplier’s stock valued at $317,000 after purchasing an additional 1,899 shares during the last quarter. Bridge City Capital LLC grew its position in shares of Utah Medical Products by 43.4% in the first quarter. Bridge City Capital LLC now owns 4,555 shares of the medical instruments supplier’s stock valued at $324,000 after purchasing an additional 1,379 shares during the last quarter. Finally, Advisory Services Network LLC grew its position in shares of Utah Medical Products by 47.8% in the fourth quarter. Advisory Services Network LLC now owns 4,885 shares of the medical instruments supplier’s stock valued at $411,000 after purchasing an additional 1,579 shares during the last quarter. Institutional investors and hedge funds own 69.60% of the company’s stock.

Utah Medical Products Stock Down 1.4 %

Shares of Utah Medical Products stock traded down $0.98 on Friday, hitting $69.48. The stock had a trading volume of 34,749 shares, compared to its average volume of 20,509. Utah Medical Products, Inc. has a twelve month low of $65.62 and a twelve month high of $98.96. The business’s 50 day moving average is $68.17 and its two-hundred day moving average is $70.75. The stock has a market cap of $245.26 million, a price-to-earnings ratio of 15.44 and a beta of 0.06.

Utah Medical Products (NASDAQ:UTMD) last posted its earnings results on Thursday, April 25th. The medical instruments supplier reported $1.09 EPS for the quarter. The company had revenue of $11.34 million for the quarter. Utah Medical Products had a return on equity of 12.35% and a net margin of 33.56%.

Utah Medical Products Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, July 5th. Investors of record on Friday, June 14th were given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 1.73%. The ex-dividend date was Friday, June 14th. Utah Medical Products’s dividend payout ratio is currently 26.67%.

About Utah Medical Products

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.